Skip to main content

Table 5 Surveillance detected cancer characteristics 

From: Randomized trial of surveillance with abbreviated MRI in women with a personal history of breast cancer– impact on patient anxiety and cancer detection

Study ID Age range Breast density (ACR) Months since dx Group Abnormality Detected by BI-RADS Histology TNM ER PR HER 2 neu
1 50 s C 25 1 Ca +  MG only 4A DCIS, intermediate nuclear grade
Initial ca: IDC, ER-Her + 
-    
2 80 s B 216 2 Mass A-MRI only 4B DCIS, high nuclear grade
Initial ca: DCIS
-    
3 40 s C 37 2 Mass A-MRI only 4B IDC, grade 2/3
Initial ca: IDC, ER + Her-
T1c N0 M0  +   +  -
4 60 s C 144 2 NME A-MRI only 4B Microinvasive lobular carcinoma, Pleomorphic lobular carcinoma in situ
Initial cancer: IDC, TN
T1miN0 M0    
5 30 s C 7 2 Mass A-MRI only 5 IDC, grade 3/3
Initial ca: IDC, ER + Her + 
T3 N2 M0 - -  + 
6 70 s C 120 2 Mass A-MRI only 5 IDC, grade 2/3, DCIS
Initial Ca: IDC, TN
T2 Nx  +  - -
7 50 s B 33 2 Mass (lung) A-MRI only N/A Adenocarcinoma consistent with breast cancer
Initial ca: IDC, ER + Her-
-  +   +  -
  1. Group 1: MG
  2. Group 2: MG plus A-MRI
  3. DCIS Ductal carcinoma in situ, IDC Invasive ductal carcinoma, TN Triple negative, ER Estrogen receptor, Her Herceptin receptor, NME Nonmass enhancement, NA Not applicable